selected publications
-
Paradigms for Precision Medicine in Epichaperome Cancer Therapy.
Cancer cell.
2019
Academic Article
GET IT
Times cited: 38 -
A novel tetrazole analogue of resveratrol is a potent anticancer agent.
Bioorganic & medicinal chemistry letters.
2018
Academic Article
GET IT
Times cited: 29 -
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations.
Blood.
2018
Academic Article
GET IT
Times cited: 23 -
The epichaperome is an integrated chaperome network that facilitates tumour survival.
Nature.
2016
Academic Article
GET IT
Times cited: 188 -
A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species.
Cell reports.
2015
Academic Article
GET IT
Times cited: 50 -
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.
Nature chemical biology.
2011
Academic Article
GET IT
Times cited: 223 -
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.
The Journal of clinical investigation.
2010
Academic Article
GET IT
Times cited: 100 -
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans.
The Journal of clinical investigation.
2010
Academic Article
GET IT
Times cited: 153 -
Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.
PloS one.
2010
Academic Article
GET IT
Times cited: 116 -
Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma.
Hepatology (Baltimore, Md.).
2009
Academic Article
GET IT
Times cited: 61 -
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.
Proceedings of the National Academy of Sciences of the United States of America.
2009
Academic Article
GET IT
Times cited: 275 -
Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
Current opinion in investigational drugs (London, England : 2000).
2006
Information Resource
GET IT
Times cited: 87 -
Ligaria cuneifolia flavonoid fractions modulate cell growth of normal lymphocytes and tumor cells as well as multidrug resistant cells.
Immunobiology.
2005
Academic Article
GET IT
Times cited: 13 -
Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia.
Toxicology and applied pharmacology.
2004
Academic Article
GET IT
Times cited: 40 -
Immunobiological features of the galactoside lectin L-Lc isolated from the Argentine mistletoe Ligaria cuneifolia.
Journal of ethnopharmacology.
2003
Academic Article
GET IT
Times cited: 19 -
[Differential binding of hyaluronic acid in 2 CD44+ sublines. Relationship with tumor infiltration].
Medicina.
2000
Academic Article
GET IT
Times cited: 2